Achievement of first significant research milestone triggers an option exercise payment of $10 million from AstraZenecaAstraZeneca will progress preclinical and clinical development of the selected ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

Weight management: Walking in the morning may help you meet your weight loss ... Reduced risk of atherosclerosis: Morning ...

As Modern Healthcare reports, CMS has relaxed supervision requirements for physical and occupational therapist assistants from “direct” to “general.” The change could help health systems manage ...

Diabetes is an epidemic across the nation – the CDC reports it affects over 37 million Americans – and what is true ...

The deals, expected to close early in 2025 pending regulatory approval: GI Alliance Holdings LLC: $2.8 billion for a 71% ...

Cardinal Health has agreed to acquire a majority stake in GI Alliance, a gastroenterology management services organization, and Advanced Diabetes Supply Group for a combined total of $3.9 billion, ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Drug distributor Cardinal Health said on Monday it will take a majority stake in gastroenterology care platform GI Alliance ...